دریافت فایل

دانلود كتب و نرم افزار دارويي

منوی اصلی

بخش های اصلی سایت

دسته بندی ها

لیست موضوعات سایت

مطالب پربازدید

لیست مطالب براساس بازدید

لینک همکاران

ثبت لینک سایت شما

اطلاعات آماری

آمار بازدیدها ، آنلاین ها و ...

  • افراد آنلاین : 0
  • ورودی گوگل امروز :
  • تعداد کل مطالب : 2366
  • تبادل لینک با : 116 سایت
  • بازدید امروز : 248
  • بازدید دیروز : 1055
  • بازدید این هفته : 8280
  • بازدید این ماه : 8280
  • بازدید کل : 82016
  • تعداد نظرات :
  • ارسال روزانه :
  • نظرات روزانه :
  • admin، فروردین ۱۰, ۱۳۹۰
  • 886 بازدید
  • داروها

  Part 1  Part 2 Part3

Drug Interactions:

It can be dangerous to administer bisoprolol concomitantly with the following medicines:

Hypoglycaemic agents, phenothiazines and various antiarrhythmic agents.

N.B. – Such medicine interactions can have life-threatening consequences. It may enhance the effects of hypoglycaemic agents in patients with diabetes mellitus as well as the effects of myocardial depressants such as lignocaine, procainamide and quinidine.

The effects may be antagonised by beta-adrenoceptor stimulating agents (e.g. isoprenaline). The hypotensive effects may be dangerously reversed by alpha-adrenoceptor stimulants. The vasoconstrictor effects may be dangerously enhanced by alpha-adrenoceptor stimulants. The effects may be enhanced by adrenergic neurone blocking agents such as guanethidine and reserpine.

The anaesthetist should be informed of bisoprolol therapy prior to any operation.

The half-life of bisoprolol can be slightly shortened by the simultaneous administration of rifampicin. An increase in the dose is generally unnecessary. The pharmacokinetics of bisoprolol are not significantly influenced by cimetidine.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:

Overdosage may produce bradycardia and severe hypotension. Bronchospasm and heart failure may be produced in certain individuals.

Bradycardia associated with severe hypotension should be treated with intravenous atropine (1 – 2 mg). If necessary this should be followed up by a slow intravenous infusion of 25 micrograms isoprenaline. Bronchospasm should be treated with intravenous aminophylline, and heart failure with digitalis and diuretics.

IDENTIFICATION:

CONCOR* 5 tablets: Light yellow, heart-shaped biconvex film-coated tablets, scored on both sides.

CONCOR* 10 tablets: Light orange, heart-shaped biconvex film-coated tablets, scored on both sides.

PRESENTATION:

Blister packs containing 30 tablets.

STORAGE INSTRUCTIONS:

Store below 25°C in airtight containers and protect from light.

Keep all medicines out of reach of children.

  Part 1  Part 2 Part3

Be Sociable, Share!
ارسال نظر
یک آواتار انتخاب کنید !

مشارکت علمی در سایت

روی تصویر کلیک کنید

فرصت های شغلی

کاریابی ابن سینا

نظرسنجی

لطفا حمایت کنید